Pinnacle Associates’s Clovis Oncology, Inc. CLVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-620,203
| Closed | -$738K | – | 779 |
|
|
2022
Q3 | $738K | Sell |
620,203
-82,501
| -12% | -$98.2K | 0.02% | 444 |
|
|
2022
Q2 | $1.27M | Sell |
702,704
-3,512
| -0.5% | -$6.32K | 0.03% | 356 |
|
|
2022
Q1 | $1.43M | Sell |
706,216
-120
| -0% | -$242 | 0.03% | 388 |
|
|
2021
Q4 | $1.91M | Buy |
706,336
+45,145
| +7% | +$122K | 0.03% | 358 |
|
|
2021
Q3 | $2.95M | Sell |
661,191
-24,790
| -4% | -$111K | 0.05% | 282 |
|
|
2021
Q2 | $3.98M | Buy |
685,981
+11,238
| +2% | +$65.2K | 0.07% | 243 |
|
|
2021
Q1 | $4.74M | Sell |
674,743
-29,227
| -4% | -$205K | 0.09% | 215 |
|
|
2020
Q4 | $3.38M | Sell |
703,970
-90,891
| -11% | -$436K | 0.07% | 240 |
|
|
2020
Q3 | $4.63M | Sell |
794,861
-33,700
| -4% | -$196K | 0.11% | 192 |
|
|
2020
Q2 | $5.59M | Sell |
828,561
-12,798
| -2% | -$86.4K | 0.14% | 163 |
|
|
2020
Q1 | $5.35M | Buy |
841,359
+212,999
| +34% | +$1.35M | 0.16% | 149 |
|
|
2019
Q4 | $6.55M | Buy |
+628,360
| New | +$6.55M | 0.14% | 166 |
|